Pulmonary embolism - Nursing Case Study
Pathophysiology
• Primary mechanism: Embolization - A thrombus, usually originating from the deep veins in the legs, travels through the venous system to lodge in the pulmonary arteries, obstructing blood flow to lung tissue.
• Secondary mechanism: Ventilation-perfusion mismatch - The obstruction in the pulmonary arteries prevents adequate blood flow to lung alveoli, disrupting the balance between air reaching the alveoli and blood flow in the pulmonary capillaries, leading to impaired gas exchange.
• Key complication: Hypoxemia - The mismatch in ventilation and perfusion causes decreased oxygen levels in the blood, leading to symptoms such as shortness of breath, chest pain, and potential cardiovascular strain or failure.
Patient Profile
Demographics:
45-year-old female, office manager
History:
• Key past medical history: Hypertension, history of deep vein thrombosis (DVT)
• Current medications: Lisinopril, Warfarin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Shortness of breath and chest pain
• Key symptoms: Dyspnea, tachycardia, mild hemoptysis, and fatigue
• Vital signs: Blood pressure 95/60 mmHg, heart rate 110 bpm, respiratory rate 26 breaths per minute, temperature 98.6°F, oxygen saturation 88% on room air
Section 1
As the clinical team initiates the assessment, the patient's condition takes a subtle yet concerning turn. Despite initial interventions, including supplemental oxygen therapy, her oxygen saturation remains stubbornly low at 90% with a simple face mask. The patient exhibits increased restlessness and anxiety, which could indicate worsening hypoxemia. On auscultation, there are diminished breath sounds bilaterally, particularly in the lower lobes, suggesting impaired ventilation in addition to perfusion issues. A repeat set of vital signs shows her heart rate has increased to 120 bpm, and the blood pressure has dropped further to 90/58 mmHg, raising concerns about potential hemodynamic instability.
The attending physician orders a series of diagnostic tests to further evaluate the extent of the pulmonary embolism and to check for any evolving complications. A CT pulmonary angiogram confirms multiple emboli in the right and left pulmonary arteries, with significant occlusion in the right lower lobe. Arterial blood gas analysis reveals respiratory alkalosis with a pH of 7.48, PaCO2 of 32 mmHg, and PaO2 of 58 mmHg, reinforcing the severity of the hypoxemic state. Additionally, a D-dimer test is elevated, consistent with a thrombotic event, and a troponin level is slightly raised, indicating possible right ventricular strain or early myocardial involvement.
Recognizing the potential for further complications, such as right heart failure or cardiogenic shock, the care team must prioritize interventions to stabilize the patient. Consideration is given to the initiation of anticoagulation therapy adjustment, possibly transitioning to heparin, while monitoring for bleeding risks due to her existing Warfarin regimen. This situation also calls for careful fluid management to support her blood pressure without exacerbating pulmonary edema. As the team contemplates these decisions, they are acutely aware of the need to balance aggressive intervention with the risk of exacerbating her pre-existing hypertension and history of DVT.
Section 2
As the clinical team closely monitors the patient following the initiation of adjusted anticoagulation therapy with heparin, they remain vigilant for any signs of bleeding complications, given her concurrent Warfarin treatment. Over the next few hours, the patient's condition presents a mixed picture. Her oxygen saturation, although slightly improved, hovers around 92% with the aid of a non-rebreather mask, indicating persistent hypoxemia. Despite these efforts, her restlessness has escalated into confusion, suggesting a potential decline in neurological status due to inadequate cerebral oxygenation. The team notes her jugular venous distension is more pronounced, hinting at increased right-sided heart strain.
A repeat echocardiogram is conducted to assess her cardiac function, revealing right ventricular dilation and moderate tricuspid regurgitation, corroborative of right heart strain secondary to the pulmonary embolism. Her blood pressure remains precariously low at 88/54 mmHg despite cautious fluid resuscitation, reinforcing the challenge of managing her hemodynamic instability without precipitating fluid overload. The combination of these findings suggests that the patient is on the brink of developing right heart failure, a complication that demands prompt and precise intervention.
In response to these developments, the care team deliberates the initiation of inotropic support to augment cardiac output and stabilize blood pressure. Additionally, the potential need for thrombolytic therapy is reconsidered, weighing the benefits of rapidly reducing the embolic burden against the heightened risk of bleeding. The clinical reasoning process now hinges on balancing these complex decisions to improve cardiac function while avoiding further deterioration. This stage of the patient's journey underscores the intricate interplay between managing acute pulmonary embolism complications and mitigating the associated risks.
Section 3
As the team initiates inotropic support with a low dose of dobutamine, they aim to enhance the patient's cardiac output and stabilize her blood pressure. Within an hour of starting the infusion, there is a modest improvement in her hemodynamics; her blood pressure rises to 98/60 mmHg, and her heart rate stabilizes around 105 beats per minute. The slight elevation in blood pressure is a welcome sign, suggesting that the intervention is beginning to take effect. However, her oxygen saturation remains stubbornly low, still fluctuating between 91% and 93% despite the non-rebreather mask, indicating ongoing respiratory compromise.
In parallel, the team revisits the possibility of thrombolytic therapy. Given the patient's deteriorating neurological status, as evidenced by her increasing confusion and agitation, the risk of a major bleeding event remains a significant concern. A repeat CT scan of her brain is ordered to preclude any intracranial pathology that could contraindicate further aggressive treatment. Concurrently, the team reviews her coagulation profile, noting an elevated INR of 3.5, reflective of her concurrent Warfarin therapy, which compounds the bleeding risk associated with thrombolytics.
The dilemma now centers on whether the potential benefit of dissolving the clot burden quickly could outweigh the risks of significant hemorrhagic complications. The team engages in a thorough discussion, considering the patient's current hemodynamic stability and persistent hypoxemia, alongside the potential for rapid deterioration into right heart failure. They decide to hold off on thrombolytics for the moment, opting instead for continued supportive care alongside close monitoring of her neurological and hemodynamic status. This decision underscores the critical balance required in managing her condition, as they aim to prevent further complications while maintaining the precarious stability achieved thus far. This phase of the patient's care journey highlights the ongoing challenge of navigating complex therapeutic decisions in the setting of acute pulmonary embolism with emerging complications.
Section 4
As the team continues to monitor the patient closely, they notice a change in her status that requires immediate attention. Approximately two hours after the initial improvement in her hemodynamics, the patient's oxygen saturation begins to decline further, dropping to 88% despite the ongoing use of a non-rebreather mask. Her respiratory rate increases to 28 breaths per minute, and auscultation reveals diminished breath sounds bilaterally with the presence of new crackles, particularly in the lower lung fields. These findings suggest worsening pulmonary compromise, potentially indicating the development of pulmonary edema or further embolic events.
In light of her deteriorating respiratory function, a repeat arterial blood gas analysis is performed, revealing a pH of 7.31, PaCO2 of 50 mmHg, and PaO2 of 55 mmHg, consistent with acute respiratory acidosis and significant hypoxemia. This prompts the team to escalate respiratory support, considering the initiation of non-invasive ventilation to improve gas exchange and reduce the work of breathing. Concurrently, a bedside echocardiogram is performed to assess for any signs of right ventricular strain or failure, given the concern for worsening right heart dysfunction as a potential driver of her declining status.
The team must now weigh the new information alongside the existing clinical picture. The decline in respiratory function and the onset of potential cardiac complications underscore the complexity of her condition, highlighting the interconnected nature of her respiratory and cardiovascular systems. The critical question remains whether the current strategy of supportive care is sufficient or whether more aggressive interventions, such as mechanical ventilation or revisiting thrombolytic therapy, should be considered to prevent further deterioration. This decision will require careful consideration of the risks and benefits, with an emphasis on maintaining the delicate balance between managing her pulmonary embolism and preventing additional complications.
Section 5
As the team deliberates on the appropriate course of action, they decide to proceed with non-invasive ventilation, opting for BiPAP to alleviate the patient's respiratory distress and improve ventilation. The BiPAP settings are initially adjusted to provide an inspiratory positive airway pressure (IPAP) of 15 cm H2O and an expiratory positive airway pressure (EPAP) of 5 cm H2O. This intervention leads to a modest improvement in the patient's respiratory rate, which decreases to 22 breaths per minute, and her oxygen saturation, which climbs to 92%. However, despite these adjustments, her work of breathing remains visibly labored, and she continues to exhibit signs of respiratory fatigue.
Simultaneously, the bedside echocardiogram reveals significant right ventricular dilation and hypokinesia, indicative of acute right heart strain secondary to the pulmonary embolism. These findings suggest that the embolic burden may be more substantial than initially anticipated, or there is potential progression of the embolic event. In light of these results, the team considers the possibility of administering systemic thrombolytics, weighing the potential benefits against the risks of bleeding. The patient's hemodynamic stability thus far supports a cautious approach, yet the escalating cardiac involvement raises concerns about impending right heart failure if the embolic load is not alleviated.
The team is now faced with the crucial decision of whether to intensify anticoagulation therapy or to escalate further to thrombolytic treatment. The aim is to restore pulmonary circulation and relieve cardiac pressure while minimizing adverse outcomes. This decision is complicated by the need to maintain adequate respiratory support and prevent further compromise, prompting the team to re-evaluate the patient's overall treatment strategy. Close monitoring remains essential as they navigate this critical juncture, ensuring that any intervention aligns with the evolving clinical scenario and optimizes the patient's chances for recovery.